CPHI & PMEC India Opens in Greater Noida

The 17th CPHI & PMEC India event, held in Greater Noida, attracted over 50,000 industry professionals, highlighting India’s pharma sector, which is projected to reach $130 billion by 2030 and $450 billion by 2047. This year's expo featured over 2,000 exhibitors, showcasing innovations in pharmaceutical manufacturing and technologies. In Hungary, Minister Márton Nagy emphasized the pharmaceutical industry's critical role in achieving over 3% GDP growth in 2024, despite challenges such as weak domestic production and external economic factors. Meanwhile, Eli Lilly and Novo Nordisk have emerged as market leaders, with a combined market cap exceeding $1.18 trillion, reflecting the industry's geographical concentration and economic significance. The success of these companies underscores the ongoing dominance of North America and Europe in the global pharmaceutical market, despite revenue disparities. As the industry evolves, strategic expansions and investments in R&D remain crucial for sustaining growth across regions.